Millennium Pharmaceuticals, Inc. (MLNM)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
3044	135	0	MLNM

Emcee: icanpickem	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
2169	Piper note: Millennium PJ Estimates (Millions except EPS) 2Q	mopgcw	-	7/12/2004
2168	Editorial on this trial: jco.org Cheers, Tuck	tuck	-	7/10/2004
2167	Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Mono	Icebrg	-	6/29/2004
2166	Targeting mitochondria to overcome conventional and Bortezomib/proteasome inhibi	Icebrg	-	6/27/2004
2165	Millennium Pharmaceuticals "neutral" Thursday, June 24, 2004 2:41:19	Icebrg	-	6/24/2004
2164	If I remember correctly, Sloan-Kettering was one of the Velcade investigators fo	Ian@SI	-	6/21/2004
2163	I can sort of see their point. Substitute "biotech CEOs" for "ant	nigel bates	-	6/21/2004
2162	This is the funniest part - <i> They also argue that it stretches the li	tom pope	-	6/21/2004
2161	If ever there were a strong sell signal for mlnm would it have been paying $11M	rkrw	-	6/21/2004
2160	>>Leuk Res. 2004 Aug;28(8):845-850. Treatment of human chronic lymphocy	tuck	-	6/21/2004
2159	Antiques, or $5 million of fakes? Mansion owneraccuses dealersof selling frauds	Icebrg	-	6/21/2004
2158	[Effects of the proteasome inhibitor bortezomib alone and in combination with ch	tuck	-	6/17/2004
2157	MLNM (IL/N): GS conf: Upbeat on Velcade. Could not confirm Integrilin guidance	mopgcw	-	6/14/2004
2156	Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell l	Icebrg	-	6/12/2004
2155	No problem - it's very early days yet. Thanks anyhow. Nigel	nigel bates	-	6/10/2004
2154	nigel, i don't recall any mention of 944. sales	software salesperson	-	6/10/2004
2153	As always, thanks, sales. (Any mention of '944 ?)	nigel bates	-	6/10/2004
2152	If you check out the MLNM Presentation made in the evening at ASCO, Slide 40, I	Gary Mohilner	-	6/10/2004
2151	6/04 gs and asco notes 270 salespeople in field use of predictive markers will	software salesperson	-	6/10/2004
2150	2 PRs just out: One reports very encouraging results for Velcade as front line	Ian@SI	-	6/9/2004
2149	Intriguing (or disappointing) to me is that MLNM is not at all talking about com	Miljenko Zuanic	-	6/8/2004
2148	SSB : MILLENNIUM PHARMACEUTICALS CONFIRMATORY PHASE III STUDY (APEX) YIELDS A	mopgcw	-	6/8/2004
2147	GS Report: MLNM (IL/N): Positive data on Velcade should re-accelerate growth.	mopgcw	-	6/8/2004
2146	I suppose they wanted to cash in on their Iloperidone and CeaVac riches before c	Icebrg	-	6/7/2004
2145	maybe titan should talk to titan, and then titan can tell us why they let piv si	scaram(o)uche	-	6/7/2004

Go to reply# or date (mm/dd/yy):